1092536-31-6

Basic information

• Product Name: benzoic acid 4-(8-benzyloxy-6-methoxy-2-phenyl-hexahydropyrano[3,2-d][1,3]dioxin-7-yloxy)-butyl ester
• Synonyms: benzoic acid 4-(8-benzyloxy-6-methoxy-2-phenyl-hexahydropyrano[3,2-d][1,3]dioxin-7-yloxy)-butyl ester
• CAS NO: 1092536-31-6
• Molecular Weight: 548.633
• Mol File: 1092536-31-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: benzoic acid 4-(8-benzyloxy-6-methoxy-2-phenyl-hexahydropyrano[3,2-d][1,3]dioxin-7-yloxy)-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: benzoic acid 4-(8-benzyloxy-6-methoxy-2-phenyl-hexahydropyrano[3,2-d][1,3]dioxin-7-yloxy)-butyl ester(1092536-31-6)
• EPA Substance Registry System: benzoic acid 4-(8-benzyloxy-6-methoxy-2-phenyl-hexahydropyrano[3,2-d][1,3]dioxin-7-yloxy)-butyl ester(1092536-31-6)

Safety Data

• Hazardous Substances Data: 1092536-31-6(Hazardous Substances Data)

Upstream product

• 36978-34-4 benzoicacid 4-bromo-butyl ester 
• 76419-48-2 methyl 4,6-O-benzylidene-3-O-benzyl-α-D-glucopyranoside 

Downstream Products

• 1092536-35-0 benzoicacid 4-(4,5-bis-benzyloxy-6-hydroxymethyl-2-methoxy-tetrahydro-pyran-3-yloxy)-butylester 
• 1192050-70-6 C₂₅H₃₂O₇ 

Relevant articles and documents

Targeting the delivery of glycan-based paclitaxel prodrugs to cancer cells via glucose transporters

This report describes the synthesis of four novel paclitaxel based prodrugs with glycan conjugation (1-4). Glycans were conjugated using an ester or ether bond as the linker between 2′-paclitaxel and the 2′-glucose or glucuronic acid moiety. These prodrug